+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Middle East & Africa Cell & Gene Therapy Business and Investment Opportunities Databook - Q2 2023 Update

  • PDF Icon

    Report

  • 300 Pages
  • August 2023
  • Region: Africa, Middle East
  • BioIntel360
  • ID: 5863828
According to the publisher, Middle East and Africa cell and gene therapy market size is expected to record a CAGR of 4.1% during 2023-2027 to reach US$0.523 billion by 2027, increasing from US$0.427 billion in 2023. Over the last five years, the sector has recorded a CAGR of 4.4% to reach US$0.409 billion in 2022.

This offering is a bundled offering, combining 4 countries and a key report covering Middle East and Africa region. This report provides an in-depth data-centric analysis of the emerging opportunities in cell and gene therapy industry in Middle East and Africa region. It covers a detailed view of market size and forecast across various segments such as by different therapy segment, type of therapy, the purpose of manufacturing, type of cell, route of administration, delivery mode, source of cell, source of manufacturing, therapeutic class, technology, end-user and by product.

This title is a bundled offering, combining the following 5 reports, covering 179+ tables and 240+ figures:

  • Country Report 1 - Middle East and Africa Cell & Gene Therapy Business and Investment Opportunities Databook - Q2 2023 Update
  • Country Report 2 - Israel Cell & Gene Therapy Business and Investment Opportunities Databook - Q2 2023 Update
  • Country Report 3 -South Africa Cell & Gene Therapy Business and Investment Opportunities Databook - Q2 2023 Update
  • Country Report 4 -Saudi Arabia Cell & Gene Therapy Business and Investment Opportunities Databook - Q2 2023 Update
  • Country Report 5 -UAE Cell & Gene Therapy Business and Investment Opportunities Databook - Q2 2023 Update

Scope

This report provides an in-depth, data-centric analysis of the Middle East & Africa cell and gene therapy market 2018-2027. Below is a summary of key market segments:

Cell & Gene Therapy Market Size by Different Therapy Segment, 2018-2027

  • Cell and Gene Modified Cell Therapies
  • Gene Therapy and Genome Therapy
  • DNA & RNA Therapeutics

Cell & Gene Therapy Market Size by Purpose of Manufacturing

  • Commercial
  • Clinical

Cell & Gene Therapy Market Size by Product

  • Abecma
  • Amondys
  • Breyanzi
  • Carvykti
  • Givlaari
  • Kimmtrak
  • Kymriah
  • Leqvio
  • Luxturna
  • Onpattro
  • Oxlumo
  • Rethymic
  • Skysona
  • Stratagraft
  • Tecartus
  • Tegsedi
  • Viltepso
  • Vyondys
  • Yescarta
  • Zolgensma
  • Zynteglo

Cell & Gene Therapy Market Size by Route of Administration

  • Injectables
  • Infusions
  • Bioscaffolds
  • Topicals

Cell & Gene Therapy Market Size by Type of Cell

  • CAR-T Cell
  • TCR Cell

Cell & Gene Therapy Market Size by Type of Therapy

  • T-Cell Therapies
  • NK Cell
  • Dendritic Cell Therapies
  • Stem Cell Therapies

Cell & Gene Therapy Market Size by Source of Cell

  • Autologous
  • Allogenic

Cell & Gene Therapy Market Size by Delivery Mode

  • In vivo
  • ex-vivo

Cell & Gene Therapy Market Size by Source of Manufacturing

  • In-House
  • Contract Manufacturing

Cell & Gene Therapy Market Size by Therapeutic Class

  • Oncology
  • Neurology
  • Ophthalmology
  • Musculoskeletal
  • Others

Cell & Gene Therapy Market Size by Technology

  • Viral Vector Technology
  • Cell Immortalization Technology
  • Genome Editing Technology
  • Others

Cell & Gene Therapy Market Size by End User

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Hospital & Clinics

Reasons to buy

  • In-depth understanding of cell and gene therapy market dynamics: Understand market opportunity, industry dynamics, key trends and drivers across different market segments and sub-segments of the industry in Middle East & Africa.
  • Develop market-specific strategies: Identify growth segments and target specific opportunities to formulate your investment strategy; assess market-specific key trends, drivers, and risks in the industry.
  • Get market share analysis by end users: Get a detailed analysis across different end users such as pharmaceutical, biotechnology companies, academic & research institutes, and by hospitals & clinics within the Middle East & Africa.

Table of Contents

This title is a bundled offering, combining the following 5 reports, covering 179+ tables and 240+ figures:
  • Country Report 1 - Middle East and Africa Cell & Gene Therapy Business and Investment Opportunities Databook - Q2 2023 Update
  • Country Report 2 - Israel Cell & Gene Therapy Business and Investment Opportunities Databook - Q2 2023 Update
  • Country Report 3 -South Africa Cell & Gene Therapy Business and Investment Opportunities Databook - Q2 2023 Update
  • Country Report 4 -Saudi Arabia Cell & Gene Therapy Business and Investment Opportunities Databook - Q2 2023 Update
  • Country Report 5 -UAE Cell & Gene Therapy Business and Investment Opportunities Databook - Q2 2023 Update
About this Report
1.1 Research Methodology
1.2 Disclaimer
2 Cell and Gene Therapy Market Size and Forecast, 2018-2027
3 Cell and Gene Therapy Market Share by Different Therapy Segment, 2018-2027
3.1 Market Size by Cell and Gene Modified Cell Therapies, 2018-2027
3.2 Market Size by Gene Therapy and Genome Therapy, 2018-2027
3.3 Cell and Gene Therapy Market Size by DNA & RNA Therapeutics, 2018-2027
4 Cell and Gene Therapy Market Share by Purpose of Manufacturing, 2018-2027
4.1 Cell and Gene Therapy Market Size by Commercial, 2018-2027
4.2 Cell and Gene Therapy Market Size by Clinical, 2018-2027
5 Cell and Gene Therapy Market Share by Product, 2018-2027
6 Cell and Gene Therapy Market Share by Route of Administration, 2018-2027
6.1 Cell and Gene Therapy Market Size by Injectables, 2018-2027
6.2 Cell and Gene Therapy Market Size by Topicals, 2018-2027
6.3 Cell and Gene Therapy Market Size by Infusions, 2018-2027
6.4 Cell and Gene Therapy Market Size by Bioscaffolds, 2018-2027
7 Cell and Gene Therapy Market Share by Type of Diseases, 2018-2027
7.1 Cell and Gene Therapy Market Size by Rare Diseases, 2018-2027
7.2 Cell and Gene Therapy Market Size by Non-Rare Diseases, 2018-2027
8 Cell and Gene Therapy Market Share by Type of Cell, 2018-2027
8.1 Cell and Gene Therapy Market Size by CAR-T Cell, 2018-2027
8.2 Cell and Gene Therapy Market Size by TCR Cell, 2018-2027
9 Cell and Gene Therapy Market Share by Therapy, 2018-2027
9.1 Cell and Gene Therapy Market Size by T-Cell Therapies, 2018-2027
9.2 Cell and Gene Therapy Market Size by NK Cell, 2018-2027
9.3 Cell and Gene Therapy Market Size by Dendritic Cell Therapies, 2018-2027
9.4 Cell and Gene Therapy Market Size by Stem Cell Therapies, 2018-2027
10 Cell and Gene Therapy Market Share by Source of Cell, 2018-2027
10.1 Cell and Gene Therapy Market Size by Autologous, 2018-2027
10.2 Cell and Gene Therapy Market Size by Allogenic, 2018-2027
11 Cell and Gene Therapy Market Share by Delivery Mode, 2018-2027
11.1 Cell and Gene Therapy Market Size by In-vivo, 2018-2027
11.2 Cell and Gene Therapy Market Size by Ex-vivo, 2018-2027
12 Cell and Gene Therapy Market Share by Source of Manufacturing, 2018-2027
12.1 Cell and Gene Therapy Market Size by In-House, 2018-2027
12.2 Cell and Gene Therapy Market Size by Contract Manufacturing, 2018-2027
13 Cell and Gene Therapy Market Share by Therapeutic Class, 2018-2027
13.1 Cell and Gene Therapy Market Size by Oncology, 2018-2027
13.2 Cell and Gene Therapy Market Size by Neurology, 2018-2027
13.3 Cell and Gene Therapy Market Size by Ophthalmology, 2018-2027
13.4 Cell and Gene Therapy Market Size by Musculoskeletal, 2018-2027
13.5 Cell and Gene Therapy Market Size by Others, 2018-2027
14 Cell and Gene Therapy Market Share by Technology, 2018-2027
14.1 Cell and Gene Therapy Market Size by Viral Vector Technology, 2018-2027
14.2 Cell and Gene Therapy Market Size by Cell Immortalization Technology, 2018-2027
14.3 Cell and Gene Therapy Market Size by Genome Editing Technology, 2018-2027
14.4 Cell and Gene Therapy Market Size by Others Technologies, 2018-2027
15 Cell and Gene Therapy Market Share by End User, 2018-2027
15.1 Cell and Gene Therapy Market Size by Pharmaceutical & Biotechnology Companies, 2018-2027
15.2 Cell and Gene Therapy Market Size by Academic & Research Institutes, 2018-2027
15.3 Cell and Gene Therapy Market Size by Hospital & Clinics, 2018-2027
16 Further Reading
16.1 About the Publisher
16.2 Related Research
16.3 Consulting

Methodology

Loading
LOADING...

Table Information